| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 1 | |
| #2 | Brazil | 1 | |
| #3 | Canada | 1 | |
| #4 | China | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Republic of Korea | 1 | |
| #7 | Mexico | 1 | |
| #8 | Philippines | 1 | |
| #9 | Singapore | 1 | |
| #10 | United States | 1 | |
| #11 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Analysing materials | |
| #3 | Medical preparations | |
| #4 | Peptides |
| # | Name | Total Patents |
|---|---|---|
| #1 | Egan James E | 8 |
| #2 | Berinstein Neil L | 8 |
| #3 | Hadden John W | 7 |
| #4 | John W Hadden | 2 |
| #5 | Neil L Berinstein | 2 |
| #6 | James E Egan | 2 |
| #7 | Hadden John | 1 |
| #8 | Berinstein Neil | 1 |
| #9 | Egan James | 1 |
| #10 | Hadden Ii John W | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3500290A1 | Uses of pd-1/pd-l1 inhibitors and/or ctla-4 inhibitors with a biologic containing multiple cytokine components to treat cancer |